Chris_CHRIS
2022-01-13
Lik pls
Can Fite's Piclidenoson Destroys Pathological Skin Cells, Lab Study Shows<blockquote>实验室研究显示，Fite的Piclidenoson可以破坏病理皮肤细胞吗</blockquote>
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":694429093,"tweetId":"694429093","gmtCreate":1642083573324,"gmtModify":1642083573600,"author":{"id":4097664093197460,"idStr":"4097664093197460","authorId":4097664093197460,"authorIdStr":"4097664093197460","name":"Chris_CHRIS","avatar":"https://static.tigerbbs.com/99bfc11e3279b5ee45705492228a37ee","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":16,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Lik pls</p></body></html>","htmlText":"<html><head></head><body><p>Lik pls</p></body></html>","text":"Lik pls","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/694429093","repostId":1141565087,"repostType":4,"repost":{"id":"1141565087","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1642082533,"share":"https://www.laohu8.com/m/news/1141565087?lang=zh_CN&edition=full","pubTime":"2022-01-13 22:02","market":"us","language":"en","title":"Can Fite's Piclidenoson Destroys Pathological Skin Cells, Lab Study Shows<blockquote>实验室研究显示，Fite的Piclidenoson可以破坏病理皮肤细胞吗</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1141565087","media":"Benzinga","summary":"Can-Fite BioPharma Ltd announced preclinical studies with skin cells, modeling psoriasis in humans, ","content":"<p><html><head></head><body><b>Can-Fite BioPharma Ltd</b> announced preclinical studies with skin cells, modeling psoriasis in humans, showing that Piclidenoson destroys pathological skin cells.</p><p><blockquote><html><head></head><body><b>康菲特生物制药有限公司</b>宣布对皮肤细胞进行临床前研究，模拟人类银屑病，表明Piclidenoson破坏病理皮肤细胞。</body></html></blockquote></p><p><ul><li>Piclidenoson is the company's lead drug candidate for the treatment of psoriasis.</li><li>The company's scientists reported that in the cell culture of human HaCaT cells, incubated with Piclidenoson, cell apoptosis was induced with an increase in the caspase protein, known to mediate apoptotic responses.</li><li>"The data shown in our lab experiments are important and support the mechanism of action of Piclidenoson and supply additional support for the drug effect. We are encouraged by the positive interim analysis data reported last year based on 200 patients' data and hope that it will be reproducible and that psoriasis patients will benefit from safety and long term relief from the symptoms of psoriasis," stated Can-Fite CEO Dr. Pnina Fishman.</li><li><b>Price Action:</b>CANF shares are up 2.24% at $1.37 during the premarket session on the last check Thursday.</li></ul></body></html></p><p><blockquote><ul><li>Piclidenoson是该公司治疗银屑病的主要候选药物。</li><li>该公司的科学家报告说，在与Piclidenoson一起孵育的人类HaCaT细胞的细胞培养物中，细胞凋亡随着已知介导凋亡反应的胱天蛋白酶蛋白的增加而被诱导。</li><li>“我们实验室实验中显示的数据很重要，支持Piclidenoson的作用机制，并为药物效果提供额外支持。我们对去年报告的基于200名患者数据的积极中期分析数据感到鼓舞，并希望它将是可重复的，银屑病患者将受益于安全性和银屑病症状的长期缓解，”Can-Fite首席执行官Pnina Fishman博士说。</li><li><b>价格走势：</b>周四最后一次盘前交易中，CANF股价上涨2.24%，至1.37美元。</li></ul></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Can Fite's Piclidenoson Destroys Pathological Skin Cells, Lab Study Shows<blockquote>实验室研究显示，Fite的Piclidenoson可以破坏病理皮肤细胞吗</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCan Fite's Piclidenoson Destroys Pathological Skin Cells, Lab Study Shows<blockquote>实验室研究显示，Fite的Piclidenoson可以破坏病理皮肤细胞吗</blockquote>\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time smaller\">2022-01-13 22:02</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<p><html><head></head><body><b>Can-Fite BioPharma Ltd</b> announced preclinical studies with skin cells, modeling psoriasis in humans, showing that Piclidenoson destroys pathological skin cells.</p><p><blockquote><html><head></head><body><b>康菲特生物制药有限公司</b>宣布对皮肤细胞进行临床前研究，模拟人类银屑病，表明Piclidenoson破坏病理皮肤细胞。</body></html></blockquote></p><p><ul><li>Piclidenoson is the company's lead drug candidate for the treatment of psoriasis.</li><li>The company's scientists reported that in the cell culture of human HaCaT cells, incubated with Piclidenoson, cell apoptosis was induced with an increase in the caspase protein, known to mediate apoptotic responses.</li><li>"The data shown in our lab experiments are important and support the mechanism of action of Piclidenoson and supply additional support for the drug effect. We are encouraged by the positive interim analysis data reported last year based on 200 patients' data and hope that it will be reproducible and that psoriasis patients will benefit from safety and long term relief from the symptoms of psoriasis," stated Can-Fite CEO Dr. Pnina Fishman.</li><li><b>Price Action:</b>CANF shares are up 2.24% at $1.37 during the premarket session on the last check Thursday.</li></ul></body></html></p><p><blockquote><ul><li>Piclidenoson是该公司治疗银屑病的主要候选药物。</li><li>该公司的科学家报告说，在与Piclidenoson一起孵育的人类HaCaT细胞的细胞培养物中，细胞凋亡随着已知介导凋亡反应的胱天蛋白酶蛋白的增加而被诱导。</li><li>“我们实验室实验中显示的数据很重要，支持Piclidenoson的作用机制，并为药物效果提供额外支持。我们对去年报告的基于200名患者数据的积极中期分析数据感到鼓舞，并希望它将是可重复的，银屑病患者将受益于安全性和银屑病症状的长期缓解，”Can-Fite首席执行官Pnina Fishman博士说。</li><li><b>价格走势：</b>周四最后一次盘前交易中，CANF股价上涨2.24%，至1.37美元。</li></ul></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CANF":"Can-Fite Biopharma Ltd"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1141565087","content_text":"Can-Fite BioPharma Ltd announced preclinical studies with skin cells, modeling psoriasis in humans, showing that Piclidenoson destroys pathological skin cells.Piclidenoson is the company's lead drug candidate for the treatment of psoriasis.The company's scientists reported that in the cell culture of human HaCaT cells, incubated with Piclidenoson, cell apoptosis was induced with an increase in the caspase protein, known to mediate apoptotic responses.\"The data shown in our lab experiments are important and support the mechanism of action of Piclidenoson and supply additional support for the drug effect. We are encouraged by the positive interim analysis data reported last year based on 200 patients' data and hope that it will be reproducible and that psoriasis patients will benefit from safety and long term relief from the symptoms of psoriasis,\" stated Can-Fite CEO Dr. Pnina Fishman.Price Action:CANF shares are up 2.24% at $1.37 during the premarket session on the last check Thursday.","news_type":1,"symbols_score_info":{"CANF":0.9}},"isVote":1,"tweetType":1,"viewCount":890,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":6,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/694429093"}
精彩评论